Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis
Li Li, … , Anne Hakem, Razq Hakem
Li Li, … , Anne Hakem, Razq Hakem
Published September 17, 2018
Citation Information: J Clin Invest. 2018;128(10):4525-4542. https://doi.org/10.1172/JCI120401.
View: Text | PDF | Corrigendum
Research Article Cell biology Oncology

Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis

  • Text
  • PDF
Abstract

The E3 ubiquitin ligase RNF8 plays critical roles in maintaining genomic stability by promoting the repair of DNA double-strand breaks (DSBs) through ubiquitin signaling. Abnormal activation of Notch signaling and defective repair of DSBs promote breast cancer risk. Here, we found that low expression of the full-length RNF8 correlated with poor prognosis for breast cancer patients. Our data revealed that in addition to its role in the repair of DSBs, RNF8 regulated Notch1 signaling and cell-fate determination of mammary luminal progenitors. Mechanistically, RNF8 acted as a negative regulator of Notch signaling by ubiquitylating the active NOTCH1 protein (N1ICD), leading to its degradation. Consistent with abnormal activation of Notch signaling and impaired repair of DSBs in Rnf8-mutant mammary epithelial cells, we observed increased risk of mammary tumorigenesis in mouse models for RNF8 deficiency. Notably, deficiency of RNF8 sensitized breast cancer cells to combination of pharmacological inhibitors of Notch signaling and poly(ADP-ribose) polymerase (PARP), suggesting implications for treatment of breast cancer associated with impaired RNF8 expression or function.

Authors

Li Li, Kiran Kumar Naidu Guturi, Brandon Gautreau, Parasvi S. Patel, Amine Saad, Mayako Morii, Francesca Mateo, Luis Palomero, Haithem Barbour, Antonio Gomez, Deborah Ng, Max Kotlyar, Chiara Pastrello, Hartland W. Jackson, Rama Khokha, Igor Jurisica, El Bachir Affar, Brian Raught, Otto Sanchez, Moulay Alaoui-Jamali, Miguel A. Pujana, Anne Hakem, Razq Hakem

×

Figure 3

Deficiency of mouse RNF8 promotes genomic instability in MECs and mammary tumors.

Options: View larger image (or click on image) Download as PowerPoint
Deficiency of mouse RNF8 promotes genomic instability in MECs and mammar...
(A) Purified MECs from WT and Rnf8–/– littermate females at estrus phase were either left untreated (UT) or irradiated (5 Gy) and fixed at the indicated time points after IR. Cells were stained with anti-γH2ax antibody and counterstained with DAPI. (B) Quantitative analysis of γH2AX subnuclear foci in WT and Rnf8–/– MECs from A. Cells with more than 3 foci were counted as foci-positive. Dot plots show mean ± SEM of 3 independent experiments, and more than 100 cells for each condition and genotype were counted. (C) Representative images of spontaneous γH2AX subnuclear foci in Rnf8–/– Trp53Δ/Δ mammary tumor cells reconstituted with RNF8 or mock (empty vector). (D) Dot plots depicting quantification of the spontaneous subnuclear foci formation for γH2AX, 53BP1, BRCA1, and RAD51 observed in Rnf8–/– Trp53Δ/Δ mammary tumor cells reconstituted with RNF8 or mock. Three independent experiments were performed, and more than 100 cells were counted for each condition and genotype (mean ± SEM). (E) Representative images of γH2AX, 53BP1, BRCA1, and RAD51 subnuclear foci formation 6 hours after IR (5 Gy) of the indicated mammary tumor cells. (F) Dot plots depicting quantifications of subnuclear foci formation observed in E. Cells harboring at least 10 foci were counted as foci-positive. Three independent experiments were performed, and more than 100 cells were counted for each condition and genotype (mean ± SEM). (G and H) Dot plots depicting efficiencies of HR-mediated (G) and NHEJ-mediated (H) repair of I-SceI–induced DSBs in Rnf8 Trp53Δ/Δ mammary tumor cells reconstituted as indicated (mean ± SEM). Three independent experiments were performed. Two-sided Student’s t test: *P < 0.05, **P < 0.01, ***P < 0.001. Scale bars: 20 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts